Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 12 studies | 34% ± 15% | |
| connective tissue cell | 8 studies | 38% ± 15% | |
| myofibroblast cell | 4 studies | 33% ± 5% |
Insufficient scRNA-seq data for expression of LRRC17 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 94% | 741.62 | 432 / 459 | 82% | 20.20 | 916 / 1118 |
| thymus | 98% | 378.79 | 637 / 653 | 70% | 7.24 | 424 / 605 |
| brain | 62% | 105.49 | 1640 / 2642 | 91% | 20.12 | 644 / 705 |
| ovary | 100% | 4772.31 | 180 / 180 | 50% | 8.01 | 216 / 430 |
| uterus | 98% | 675.34 | 167 / 170 | 40% | 18.34 | 183 / 459 |
| adrenal gland | 84% | 164.18 | 217 / 258 | 54% | 6.55 | 124 / 230 |
| pancreas | 54% | 83.59 | 177 / 328 | 78% | 10.32 | 139 / 178 |
| prostate | 93% | 351.47 | 228 / 245 | 35% | 1.68 | 176 / 502 |
| bladder | 95% | 269.14 | 20 / 21 | 29% | 3.22 | 147 / 504 |
| stomach | 92% | 467.81 | 332 / 359 | 27% | 2.19 | 78 / 286 |
| kidney | 64% | 133.08 | 57 / 89 | 54% | 6.93 | 484 / 901 |
| lung | 61% | 179.20 | 354 / 578 | 53% | 5.96 | 611 / 1155 |
| skin | 88% | 317.18 | 1586 / 1809 | 23% | 7.17 | 108 / 472 |
| esophagus | 67% | 306.05 | 971 / 1445 | 43% | 6.55 | 79 / 183 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.60 | 1 / 1 |
| blood vessel | 99% | 1541.82 | 1325 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 88% | 475.91 | 1061 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 64% | 161.54 | 615 / 966 | 23% | 2.20 | 119 / 527 |
| heart | 86% | 473.88 | 737 / 861 | 0% | 0 | 0 / 0 |
| liver | 43% | 78.15 | 97 / 226 | 18% | 1.82 | 73 / 406 |
| muscle | 45% | 77.18 | 359 / 803 | 0% | 0 | 0 / 0 |
| spleen | 43% | 76.18 | 103 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 29% | 3.21 | 13 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048539 | Biological process | bone marrow development |
| GO_0033687 | Biological process | osteoblast proliferation |
| GO_0001649 | Biological process | osteoblast differentiation |
| GO_0045671 | Biological process | negative regulation of osteoclast differentiation |
| GO_0005615 | Cellular component | extracellular space |
| GO_0031012 | Cellular component | extracellular matrix |
| Gene name | LRRC17 |
| Protein name | Leucine-rich repeat-containing protein 17 (p37NB) Leucine rich repeat containing 17 |
| Synonyms | UNQ3076/PRO9909 P37NB |
| Description | FUNCTION: Involved in bone homeostasis. Acts as a negative regulator of RANKL-induced osteoclast precursor differentiation from bone marrow precursors (By similarity). . |
| Accessions | ENST00000339431.9 [Q8N6Y2-1] ENST00000455453.1 Q8N6Y2 ENST00000249377.4 [Q8N6Y2-2] C9JT74 |